A Johnson & Johnson Play Ahead of Earnings

These calls are a real value with earnings coming up.

AMC Is a High Risk, High Reward Play

Short and sweet: This is based on the high running emotions of the markets. There's little to it beyond that.

GoodRx Needs a Shot in the Arm to Improve Its Outlook

IPOs in recent months have done extremely well -- not so GDRX.

2021 and 2022 Look Difficult for Intel, While 2023 -- Might -- Be Better

Competition from AMD and ARM CPU developers looks set to take a toll over the next two years. But Intel could be in better shape in 2023 if its new CEO is ready to make some tough choices.

GameStop and the Dangerous Game of Gamma Squeezes

What happened after Citron Research posted a video about GameStop is very troubling.

Stocks Are Well Off Early Lows, but There's Still Quite a Bit of Weakness

There is still strong interest in stock picking which is the most positive thing about this market.

Jim Cramer: The Market Now Acts Like a Market of Stocks Than a Bushel or a Peck

There was a period before the time of commoditization where individual elan and corporate dominance meant something. And that's back.

Looking for Higher Highs After a Trex Correction

Some new accumulation (buying) around the $85 area should set the stage for further gains.

Oil Specs Are All in and Long - Too Much Too Soon?

Oil is especially interesting as it is deemed the cheapest. Cheap is cheap for a reason.

Intel Disappoints and Its Stock Suffers

When the chipmaker turns lower you need to get out the way.